Biblio Discovery — Demo Discovery Service

122 hasil

Menampilkan 1–20 · 0,15 detik · RSS

Jurnal

Journal of Cardiovascular Pharmacology and Therapeutics

Scopus

ISSN 1940-4034 · SAGE Publishing · 122 artikel di indeks

  1. Artikel Jurnal

    Adherence to Direct Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation: A Single-Center Retrospective Study

    Cuie Chang; Sha Lv; Lingyan Yu dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Objective To investigate adherence to four direct oral anticoagulants (DOACs) and its influencing factors in patients with non-valvular atrial fibrillation (NVAF), providing evidence for strategies to improve adherence. Methods A retrospective cohort study included NVAF patients initiating DOAC…

  2. Artikel Jurnal

    Norepinephrine Versus Dopamine as Vasoactive Therapy in Cardiogenic Shock: Association With 28-Day Mortality in a Retrospective Cohort Study

    Suthida Chanchenchop PharmD; Supanee Sinphurmsukskul MD; Krittin Bunditanukul PharmD, PhD, BCPS

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Cardiogenic shock remains a life-threatening condition with persistently high mortality. Norepinephrine and dopamine are commonly used vasoactive agents; however, comparative data on clinical outcomes remain limited. Methods This retrospective cohort study included 388 adults with…

  3. Artikel Jurnal

    ABCD-GENE Score and Bleeding in Post-PCI Patients: Implications for Guided De-Escalation of Antiplatelet Therapy

    James C. Coons PharmD, FCCP, FACC, BCCP; Kathleen Polkowski PharmD; Linda Prebehalla BSN, RN dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background The ABCD-GENE (Age, Body Mass Index, Chronic Kidney Disease, Diabetes Mellitus, and Genotyping) score is a tool used to identify increased thrombotic risk in clopidogrel-treated patients. We evaluated the association between a low ABCD-GENE score (

  4. Artikel Jurnal

    Effects of Vericiguat on Peripheral Vascular Function and Resting/Exercise Hemodynamics in Patients With Heart Failure With Reduced Ejection Fraction: An Exploratory Pilot Study

    Yohei Funauchi MD; Toru Takase MD, PhD; Kazuyoshi Kakehi MD, PhD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Vericiguat improves outcomes in heart failure with reduced ejection fraction (HFrEF), but its vascular and hemodynamic effects remain unclear. We explored changes in flow-mediated dilation (FMD) and invasive hemodynamics after vericiguat in symptomatic patients with HFrEF receiving…

  5. Artikel Jurnal

    Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study

    Hrvoje Jurin; Irzal Hadžibegović; Jure Samardžić dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Platelet reactivity varies after ST-segment-elevation myocardial infarction (STEMI). We evaluated serial platelet function-guided P2Y12 modulation after a 1-month ticagrelor run-in. Methods At month 1, 114 patients were randomized to continued ticagrelor (n=59) or an adenosine…

  6. Artikel Jurnal

    Targeting Aldosterone Biosynthesis in Uncontrolled and Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials of Lorundrostat and Baxdrostat

    Ravi Pandey MBBS; Muhammad Ahmad MBBS; Ali Rohan MBBS dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Aldosterone excess contributes to uncontrolled and resistant hypertension, making aldosterone synthase inhibition a promising therapeutic strategy. Recent randomized trials have evaluated the selective aldosterone synthase inhibitors Lorundrostat and Baxdrostat; however, their efficacy…

  7. Artikel Jurnal

    Alterations of Platelet MicroRNAs Associated With Dapagliflozin Treatment in Individuals With Type 2 Diabetes Mellitus

    Feng Chen MD; Xueyan Ding MD; Feifei Dong MD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Platelet hyperactivity contributes to elevated cardiovascular risk in type 2 diabetes mellitus (T2DM). Sodium-glucose cotransporter-2 inhibitors, including dapagliflozin, exert beneficial effects on platelet function and cardiovascular outcomes. As platelet microRNAs (miRNAs) are…

  8. Artikel Jurnal

    Comparative Effectiveness of Renin-Angiotensin System Inhibitors in Heart Failure With Nonreduced Ejection Fraction: A Multicenter Cohort Study

    Ming-Shyan Lin MD; Po-Chang Wang MD; Jung-Jung Chang MD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background The comparative effectiveness of angiotensin-converting enzyme inhibitors (ACEis) versus angiotensin receptor blockers (ARBs) in heart failure with nonreduced ejection fraction (HFnon-rEF) remains uncertain. We evaluated long-term outcomes of these therapies in a real-world cohort…

  9. Artikel Jurnal

    Factors Associated With Loop Diuretic De-escalation in Patients With Acute Decompensated Heart Failure: The Influence of Guideline Directed Medical Therapy Initiation

    Satoshi Hanazawa B.Pharm; Noriko Kohyama PhD; Erika Iwasaki PhD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background In patients with heart failure (HF), loop diuretics (LD) are recommended to relieve congestion and may be de-escalated if symptoms improve. However, long-term use of the same LD dose is sometimes required owing to potential congestion exacerbation. Therefore, we investigated the factors…

  10. Artikel Jurnal

    Shared Genetic Liability Between Heart Failure and Myocardial Infarction Revealed by Genome-Wide Cross-Trait Analysis

    Ruikang Liu MS; Chiyun Sun MS; Nan Jiang PhD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background The extent and biological relevance of shared genetic architecture between myocardial infarction (MI) and heart failure (HF) remain incompletely understood. Methods We analyzed large-scale European-ancestry genome-wide association studies summary statistics for MI and HF. Genome-wide…

  11. Artikel Jurnal

    Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam

    Huan Thanh Nguyen MD, PhD; Huong Thi Mai Nguyen MD, MS; Kieu Dang Phuong Nguyen MD, MS dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Heart failure (HF) is common among older adults; however, data on phenotype distribution and real-world pharmacologic management remain limited. This study assessed the prevalence of guideline-directed medical therapy (GDMT) underuse across HF phenotypes and identified factors associated…

  12. Artikel Jurnal

    Optimal Switching Antiplatelet Regimen in Patients with Ticagrelor to a Thienopyridine in Korean Patients (SWAPT-K Study)

    Hyoun-Woo Noh MD; Sung-Hyo Seo PhD; Yong-Lee Kim MD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Dual antiplatelet therapy (DAPT) with aspirin and potent P2Y 12 inhibitors such as ticagrelor effectively reduces ischemic events but increases bleeding risk. In patients requiring long-term DAPT, switching from ticagrelor to a thienopyridine is often considered to reduce bleeding risk…

  13. Artikel Jurnal

    Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study

    Fawaz H Tawhari PharmD; Mohammad F Zaitoun BSc(Pharm), PharmD, MBA, CPHQ; Ehab Elmongui BSc(Pharm), PharmD, MSc, PhD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Acute coronary syndrome (ACS) remains a leading cause of mortality globally. Dual antiplatelet therapy (DAPT) is standard after percutaneous coronary intervention (PCI). While ticagrelor has demonstrated favorable myocardial effects in preclinical studies, limited clinical data compared…

  14. Artikel Jurnal

    Eleutheroside E Attenuates Doxorubicin-Induced Cardiotoxicity by Suppressing Ferroptosis Through Activation of the Nrf2/SLC7A11/GPX4 Signaling Pathway

    Peng Sun MD; Liheng Chen MD; Xiangzhou Chen MD dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Doxorubicin (DOX)-induced cardiotoxicity significantly impairs cancer patient survival rates. Eleutheroside E (EE), a polyphenolic compound with established cardioprotective properties against high-altitude myocardial injury and ischemia/reperfusion damage, has not previously been investigated in…

  15. Artikel Jurnal

    Factors Associated With the Selection of Anti-Hypertensive Medications: A Retrospective Cross-Sectional Analysis

    Aymen Alqurain PhD; Arif Aldihani BPharm; Hadeel Almousa BPharm dkk.

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 31 · 2026 · Inggris · DOAJ Scopus

    Background Hypertension remains a leading modifiable risk factor for cardiovascular disease, and effective anti-hypertensive prescribing is essential for optimal management. This study will evaluate the patterns of anti-hypertensive prescriptions, characteristics of specific drug class users, and…